← Leaderboards
Rawan Tarawneh
Ohio State University
$2,348,614
Attributed
$2,557,097
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2020–23$2.5M$1.9M$1.3M$625K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$2,557,097 · 2
By mechanism
RF1$2,140,130 · 1
R21$416,967 · 1
Top collaborators
- Amal O Amer2 shared
Most similar at Ohio State University
Same institution · by research overlap
- Daniel J Wozniak$19,868,004
- Amal O Amer$14,350,541
- Macarius M. Donneyong$2,664,701
- Ai Ni$1,685,864
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposCerebrospinal FluidDiagnostic BiomarkerPathologyS Disease BrainAlzheimerâS Disease BiomarkerLiquid SubstanceInsightNeuronsPathologicProteinsS DiseaseBiological MarkersBloodPrognostic MarkerBrainDisease ProgressionImpaired CognitionAmyloidNerve DegenerationPathogenesisAmyloid DepositionBiologicalBinding
Grant awards (3)
Elucidating the Role of Endothelial Dysfunction in Alzheimer Disease: Towards A New Data-Driven Disease Model$2,140,130
RF1 · FY2023 · AG · contact PI
Alzheimerâs Disease Biomarker for Diagnosis and Prognosis$188,808
R21 · FY2021 · AG
Alzheimer's Disease Biomarker for Diagnosis and Prognosis$228,159
R21 · FY2020 · AG